谷歌浏览器插件
订阅小程序
在清言上使用

Longer Term Follow-up of a Multicenter, Phase 2 Study of Ibrutinib Plus Fludarabine, Cyclophosphamide, Rituximab (ifcr) As Initial Therapy for Younger Patients with Chronic Lymphocytic Leukemia

Blood(2021)

引用 3|浏览33
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要